RCM
RA Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,930,322
| Closed | -$28.5M | – | 94 |
|
|
2022
Q1 | $28.5M | Hold |
1,930,322
| – | – | 0.62% | 47 |
|
|
2021
Q4 | $25.5M | Hold |
1,930,322
| – | – | 0.45% | 54 |
|
|
2021
Q3 | $33.7M | Hold |
1,930,322
| – | – | 0.47% | 49 |
|
|
2021
Q2 | $46.3M | Buy |
1,930,322
+1,580,322
| +452% | +$37.9M | 0.74% | 44 |
|
|
2021
Q1 | $8.99M | Buy |
+350,000
| New | +$8.99M | 0.14% | 74 |
|
|
2019
Q2 | – | Sell |
-1,441,070
| Closed | -$41.2M | – | 29 |
|
|
2019
Q1 | $41.2M | Hold |
1,441,070
| – | – | 1.78% | 16 |
|
|
2018
Q4 | $28.5M | Hold |
1,441,070
| – | – | 1.66% | 17 |
|
|
2018
Q3 | $31.9M | Hold |
1,441,070
| – | – | 1.7% | 18 |
|
|
2018
Q2 | $11.7M | Hold |
1,441,070
| – | – | 0.76% | 22 |
|
|
2018
Q1 | $13.7M | Hold |
1,441,070
| – | – | 1.05% | 19 |
|
|
2017
Q4 | $14.1M | Buy |
1,441,070
+850,000
| +144% | +$8.29M | 1.18% | 18 |
|
|
2017
Q3 | $4.35M | Hold |
591,070
| – | – | 0.39% | 25 |
|
|
2017
Q2 | $4.35M | Hold |
591,070
| – | – | 0.5% | 21 |
|
|
2017
Q1 | $4.62M | Hold |
591,070
| – | – | 0.57% | 22 |
|
|
2016
Q4 | $4.18M | Buy |
+591,070
| New | +$4.18M | 0.59% | 21 |
|